NCT04038567

Brief Summary

This is a factorial experimental trial involving adult survivors of cardiorespiratory failure treated in intensive care units (ICUs) that is conceptualized as the Optimization Phase of a multiphase optimization strategy (MOST) framework. This will allow optimization of a mobile mindfulness intervention by comparing eight different iterations across domains including impact on symptoms, feasibility, acceptability, usability, scalability, and cost.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
247

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Aug 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 24, 2019

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 31, 2019

Completed
15 days until next milestone

Study Start

First participant enrolled

August 15, 2019

Completed
3.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2023

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 19, 2023

Completed
1.1 years until next milestone

Results Posted

Study results publicly available

August 15, 2024

Completed
Last Updated

August 15, 2024

Status Verified

July 1, 2024

Enrollment Period

3.7 years

First QC Date

July 24, 2019

Results QC Date

April 17, 2024

Last Update Submit

July 23, 2024

Conditions

Keywords

cardiorespiratory failurecritical illnesspsychological distressdepressionanxietypost-traumatic stress disorderintensive care unitsadultsmechanical ventilation

Outcome Measures

Primary Outcomes (1)

  • Patient Health Questionnaire-9 Item Scale (PHQ-9)

    Absolute values, not change scores. Depression symptoms. Scores range from 0 (better) to 27 (worse)

    1 month post-randomization

Secondary Outcomes (23)

  • Generalized Anxiety Disorder 7-item Scale (GAD-7)

    Between baseline 1 month post-randomization

  • Patient Health Questionnaire-9 Item Scale (PHQ-9)

    Between baseline 3 months post-randomization

  • Generalized Anxiety Disorder 7-item Scale (GAD-7)

    Between baseline 3 months post-randomization

  • Post-Traumatic Stress Symptom Inventory (PTSS)

    Between baseline 3 months post-randomization

  • Intervention Adherence: Activity in App During Final Week of Intervention

    1 month post-randomization

  • +18 more secondary outcomes

Study Arms (6)

App introduction to intervention

OTHER

Introduction to intervention via the mobile app itself.

Behavioral: Mobile mindfulness-based training

Therapist introduction to intervention

OTHER

Introduction to intervention via a call from the study therapist.

Behavioral: Mobile mindfulness-based training

Standard dose

OTHER

Standard dose of meditation time (once a day).

Behavioral: Mobile mindfulness-based training

High dose

OTHER

High dose of meditation time (twice a day).

Behavioral: Mobile mindfulness-based training

App response to symptoms

OTHER

Mobile app response to elevated psychological distress symptoms during intervention period.

Behavioral: Mobile mindfulness-based training

Therapist response to symptoms

OTHER

Therapist call in response to elevated psychological distress symptoms during intervention period.

Behavioral: Mobile mindfulness-based training

Interventions

The intervention core is a mobile app-based mindfulness training program designed to be used over a 1-month period. All 6 factorial groups will use the app, though the delivery of the app and response to psychological distress symptoms over time will differ by group.

App introduction to interventionApp response to symptomsHigh doseStandard doseTherapist introduction to interventionTherapist response to symptoms

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult (age ≥18)
  • Acute cardiorespiratory failure:
  • Acute respiratory failure, defined as ≥1 of the following:
  • mechanical ventilation via endotracheal tube for ≥12 hours
  • non-invasive ventilation (CPAP, BiPAP) for ≥4 hours in a 24-hour period provided for acute respiratory failure in an ICU (not for obstructive sleep apnea or other stable use)
  • high flow nasal cannula or face mask oxygen for ≥4 hours in a 24-hour period and / or
  • Acute cardiac / circulatory failure, defined as ≥1 of the following:
  • use of vasopressors for shock of any etiology for ≥1 hour
  • use of inotropes for shock of any etiology for ≥1 hour
  • use of pulmonary vascular vasoactive medications
  • use of aortic balloon pump for cardiogenic shock for ≥1 hour
  • Cognitive status intact
  • No history of pre-existing significant cognitive impairment (e.g., dementia) as per medical chart
  • Absence of current significant cognitive impairment (impairment defined as ≥3 errors on the Callahan cognitive status screen)
  • Decisional capacity present
  • +5 more criteria

You may not qualify if:

  • Hospitalized within the preceding 3 months with life-threatening illness or injury.
  • Patients may be enrolled into the study if they had a hospitalization within the preceding 3 months that is determined to be non-serious. Non-serious admissions are defined as those admissions that are non-life threatening and/or potentially impacting patient's well-being long-term or likely to precipitate additional future admissions. Examples of non-life-threatening hospitalizations could be, but may not be limited to, admission for a bronchoscopy, admission for deep vein thrombosis, or admission to ED resulting in overnight stay for cardiac work-up.
  • Admitted from a location other than home (e.g., nursing home, long-term acute care facility, inpatient rehabilitation facility)
  • Anticipated or actual discharge to a location other than independent in a home setting (e.g., nursing home, long-term acute care facility, inpatient rehabilitation facility, home hospice)
  • Complex medical care expected soon after discharge (e.g., planned surgeries, transplantation evaluation, extensive travel needs for hemodialysis, disruptive chemotherapy/radiation regimen)
  • Unable to complete study procedures as determined by staff
  • Lack of reliable smartphone with cellular data plan or wifi access
  • Low baseline psychological distress symptoms, defined as the absence of the following at T1: PHQ-9 score \<5
  • Failure to randomize within 2 month (60 days) post-discharge.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

University of Colorado - Denver

Aurora, Colorado, 80045, United States

Location

Duke University Medical Center

Durham, North Carolina, 27710, United States

Location

University of Washington

Seattle, Washington, 98195, United States

Location

Related Publications (4)

  • Cox CE, Porter LS, Buck PJ, Hoffa M, Jones D, Walton B, Hough CL, Greeson JM. Development and preliminary evaluation of a telephone-based mindfulness training intervention for survivors of critical illness. Ann Am Thorac Soc. 2014 Feb;11(2):173-81. doi: 10.1513/AnnalsATS.201308-283OC.

    PMID: 24303911BACKGROUND
  • Cox CE, Hough CL, Jones DM, Ungar A, Reagan W, Key MD, Gremore T, Olsen MK, Sanders L, Greeson JM, Porter LS. Effects of mindfulness training programmes delivered by a self-directed mobile app and by telephone compared with an education programme for survivors of critical illness: a pilot randomised clinical trial. Thorax. 2019 Jan;74(1):33-42. doi: 10.1136/thoraxjnl-2017-211264. Epub 2018 May 23.

    PMID: 29793970BACKGROUND
  • Cox CE, Olsen MK, Gallis JA, Porter LS, Greeson JM, Gremore T, Frear A, Ungar A, McKeehan J, McDowell B, McDaniel H, Moss M, Hough CL. Optimizing a self-directed mobile mindfulness intervention for improving cardiorespiratory failure survivors' psychological distress (LIFT2): Design and rationale of a randomized factorial experimental clinical trial. Contemp Clin Trials. 2020 Sep;96:106119. doi: 10.1016/j.cct.2020.106119. Epub 2020 Aug 15.

    PMID: 32805434BACKGROUND
  • Cox CE, Gallis JA, Olsen MK, Porter LS, Gremore T, Greeson JM, Morris C, Moss M, Hough CL. Mobile Mindfulness Intervention for Psychological Distress Among Intensive Care Unit Survivors: A Randomized Clinical Trial. JAMA Intern Med. 2024 Jul 1;184(7):749-759. doi: 10.1001/jamainternmed.2024.0823.

MeSH Terms

Conditions

Critical IllnessDepressionAnxiety DisordersStress Disorders, Post-Traumatic

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsBehavioral SymptomsBehaviorMental DisordersStress Disorders, TraumaticTrauma and Stressor Related Disorders

Results Point of Contact

Title
Christopher Cox
Organization
Duke University

Study Officials

  • Christopher E Cox, MD

    Duke University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
PIs and analysts blinded to allocation. Outcomes completed by participants using web-based interface and thus outcomes assessors as such are blinded.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Factorial experimental trial as part of a multi-phase optimization strategy (MOST) design
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 24, 2019

First Posted

July 31, 2019

Study Start

August 15, 2019

Primary Completion

May 1, 2023

Study Completion

July 19, 2023

Last Updated

August 15, 2024

Results First Posted

August 15, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will share

We will follow NIH/NCCIH guidelines for data access.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
We will follow NIH and institutional guidelines.
Access Criteria
We will follow NIH and institutional guidelines. Given the length of time that will elapse during the study, we will need to adhere to the rules present at that time.

Locations